GlassScriptPhysician profile
Thomas R Trimbur
NPI 1467470757
$7,746.03
in general payments reported to CMS, 2019-2025
34 companies · $88.61 in 2025
The $88.61 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,238 · 2020: $532 · 2021: $336 · 2022: $2,062 · 2023: $1,999 · 2024: $1,492 · 2025: $88.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,579.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,578.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,399.92 | 2019-2025 | Leqvio |
| Astrazeneca Pharmaceuticals LP | $1,268.90 | 2019-2024 | Airsupra, Farxiga, Wainua |
| Glaxosmithkline, LLC. | $705.56 | 2019-2024 | Arexvy |
| Amgen INC. | $476.92 | 2022-2023 | Repatha, Evenity |
| E.R. Squibb & Sons, L.L.C. | $357.27 | 2020-2024 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $344.16 | 2021-2025 | Verquvo |
| Novo Nordisk INC | $292.57 | 2022-2023 | Rybelsus, Ozempic |
| Janssen Pharmaceuticals, INC | $289.97 | 2019-2023 | Xarelto |
| Pfizer INC. | $280.67 | 2019-2024 | |
| Medtronic, INC. | $249.44 | 2022-2024 | Minimed 780g |
| Boston Scientific Corporation | $220.83 | 2022-2025 | Bodyguardian, Watchman Access System, Watchman Flx |
| Lilly USA, LLC | $194.43 | 2022-2023 | Mounjaro |
| Lexicon Pharmaceuticals, INC. | $157.90 | 2023-2024 | Inpefa |
| Sanofi-Aventis U.S. LLC | $148.73 | 2019-2022 | |
| Baxter Healthcare | $133.25 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $125.93 | 2022 | |
| Phathom Pharmaceuticals, INC. | $121.01 | 2024 | Voquezna |
| Amarin Pharma, INC. | $119.70 | 2023 | |
| Lucid Diagnostics INC. | $116.61 | 2022 | |
| Exact Sciences Corporation | $113.65 | 2023 | Cologuard Collection Kit |
| Esperion Therapeutics, INC. | $111.61 | 2022 | |
| Organogenesis INC. | $108.07 | 2023 | Puraply |
| Bayer Healthcare Pharmaceuticals INC. | $60.93 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.13 | 2022-2023 | Jardiance |
| Vital Connect, INC | $50.58 | 2023-2024 | Vitalpatch Rtm |
| Alnylam Pharmaceuticals INC. | $44.30 | 2023-2024 | Onpattro |
| Philips North America LLC | $39.59 | 2023-2024 | (Ck4) Mcot |
| Inspire Medical Systems, INC. | $30.92 | 2023-2024 | Inspire |
| Actelion Pharmaceuticals US, INC. | $29.37 | 2023 | Opsumit, Uptravi |
| Scpharmaceuticals INC. | $27.72 | 2024 | |
| Abbott Laboratories | $23.34 | 2021 | |
| Chiesi USA, INC. | $16.75 | 2020 | |
| Irhythm Technologies, INC. | $14.28 | 2024 | Zio Xt Patch, Zio Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Trimbur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.